IBM announced its intent to acquire Applications Software Technology LLC, a global Oracle consultancy-which would bring deep expertise driving business transformations with Oracle Cloud Applications, ...
The new approval covers Kisqali's use in combination with an aromatase inhibitor (AI) in patients with HR+/HER2- early breast cancer at high risk of recurrence. Previously, the drug was approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback